Integrated approaches to safety testing: General principles and skin sensitization as test case

Issues in Toxicology

Volumn , Issue , 2014, Pages 265-288

  Natsch, Andreas ^a  

^a GIVAUDAN SCHWEIZ AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84898737679     PISSN: 17577179     EISSN: 17577187     Source Type: Book Series    
DOI: None     Document Type: Article

References (83)

1. H. Spielmann, S. Hoffmann, M. Liebsch, P. Botham, J. H. Fentem, C. Eskes, R. Roguet, J. Cotovio, T. Cole, A. Worth, J. Heylings, P. Jones, C. Robles, H. Kandarova, A. Gamer, M. Remmele, R. Curren, H. Raabe, A. Cockshott, I. Gerner and V. Zuang, The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test, Altern. Lab. Anim., 2007, 35, 559-601.
2. M. Ceridono, P. Tellner, D. Bauer, J. Barroso, N. Alepee, R. Corvi, A. De Smedt, M. D. Fellows, N. K. Gibbs, E. Heisler, A. Jacobs, D. Jirova, D. Jones, H. Kandarova, P. Kasper, J. K. Akunda, C. Krul, D. Learn, M. Liebsch, A. M. Lynch, W. Muster, K. Nakamura, J. F. Nash, U. Pfannenbecker, G. Phillips, C. Robles, V. Rogiers, F. Van De Water, U. W. Liminga, H. W. Vohr, O. Wattrelos, J. Woods, V. Zuang, J. Kreysa and P. Wilcox, The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing-the report of an ECVAM-EFPIA workshop, Regul. Toxicol. Pharmacol., 2012, 63, 480-488.
3. K. Maier, R. Schmitt-Landgraf and B. Siegemund, Development of an in vitro test system with human skin cells for evaluation of phototoxicity, Toxicol. In Vitro, 1991, 5, 457-461.
4. M. Bouhifd, G. Bories, J. Casado, S. Coecke, H. Norlen, N. Parissis, R. M. Rodrigues and M. P. Whelan, Automation of an in vitro cytotoxicity assay used to estimate starting doses in acute oral systemic toxicity tests, Food. Chem. Toxicol, 2012, 50, 2084-2096.
5. D. Kirkland, L. Reeve, D. Gatehouse and P. Vanparys, A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins, Mutat Res., 2011, 721, 27-73.
6. J. Jaworska, S. Gabbert and T. Aldenberg, Towards optimization of chemical testing under REACH: a Bayesian network approach to Integrated Testing Strategies, Regul. Toxicol. Pharmacol., 2010, 57, 157-167.
7. R. Combes, C. Grindon, M. T. Cronin, D. W. Roberts and J. F. Garrod, Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation, Altern. Lab Anim., 2008, 36, 45-63.
8. C. Grindon, R. Combes, M. T. Cronin, D. W. Roberts and J. F. Garrod, An integrated decision-tree testing strategy for skin sensitisation with respect to the requirements of the EU REACH legislation, Altern. Lab Anim., 2008, 36(Suppl 1), 75-89.
9. C. Grindon, R. Combes, M. T. Cronin, D. W. Roberts and J. F. Garrod, An integrated decision-tree testing strategy for repeat dose toxicity with respect to the requirements of the EU REACH legislation, Altern. Lab Anim., 2008, 36, 93-101.
10. C. Grindon, R. Combes, M. T. Cronin, D. W. Roberts and J. F. Garrod, An integrated decision-tree testing strategy for eye irritation with respect to the requirements of the EU REACH legislation, Altern. Lab Anim., 2008, 36, 81-92.
11. C. Rovida, Food for thought... why no new in vitro tests will be done for REACH by registrants, ALTE, 2010, 27, 175-183.
12. C. Rovida and F. Longo, R. R. Rabbit, How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?, ALTEX, 2011, 28, 273-294.
13. C. Rovida, Local lymph node assay: how testing laboratories apply OECD TG 429 for REACH purposes, ALTEX, 2011, 28, 117-129.
14. G. T. Ankley, R. S. Bennett, R. J. Erickson, D. J. Hoff, M. W. Hornung, R. D. Johnson, D. R. Mount, J. W. Nichols, C. L. Russom, P. K. Schmieder, J. A. Serrrano, J. E. Tietge and D. L. Villeneuve, Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment, Environ. Toxicol. Chem., 2010, 29, 730-741.
15. B. De Wever, H. W. Fuchs, M. Gaca, C. Krul, S. Mikulowski, A. Poth, E. L. Roggen and M. R. Vila, Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation, Toxicol. In Vitro, 2012, 26, 526-534.
16. National-Research-Council, Toxicity Testing in the 21st Century. A Vision and a Strategy. National Academies Press: Washington, DC, 2007.
17. T. Hartung, E. Van Vliet, J. Jaworska, L. Bonilla, N. Skinner and R. Thomas, Food for thought... Systems toxicology, ALTEX, 2012, 29, 119-128.
18. J. Dumont, R. Josse, C. Lambert, S. Antherieu, L. Le Hegarat, C. Aninat, M. A. Robin, C. Guguen-Guillouzo and A. Guillouzo, Differential toxicity of heterocyclic aromatic amines and their mixture in metabolically competent HepaRG cells, Toxicol. Appl. Pharmacol., 2010, 245, 256-263.
19. L. Birrell, P. Cahill, C. Hughes, M. Tate and R. M. Walmsley, GADD45a-GFP GreenScreen HC assay results for the ECVAM recommended lists of genotoxic and non-genotoxic chemicals for assessment of new genotoxicity tests, Mutat. Res., 2010, 695, 87-95.
20. P. C. Von Der Ohe, R. Kuhne, R. U. Ebert, R. Altenburger, M. Liess and G. Schuurmann, Structural alerts-a new classification model to discriminate excess toxicity from narcotic effect levels of organic compounds in the acute daphnid assay, Chem. Res. Toxicol., 2005, 18, 536-555.
21. D. W. Roberts and A. O. Aptula, Determinants of skin sensitisation potential, Journal of Applied Toxicology, 2008, 28, 377-387.
22. C. Jagger, M. Tate, P. A. Cahill, C. Hughes, A. W. Knight, N. Billinton and R. M. Walmsley, Assessment of the genotoxicity of S9-generated metabolites using the GreenScreen HC GADD45a-GFP assay., Mutagenesis, 2009, 24, 35-50.
23. J. Zheng, L. Ma, B. Xin, T. Olah, W. G. Humphreys and M. Zhu, Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry, Chemical Research in Toxicology, 2007, 20, 757-766.
24. A. T. Karlberg, M. A. Bergstrom, A. Borje, K. Luthman and J. L. Nilsson, Allergic contact dermatitis-formation, structural requirements, and reactivity of skin sensitizers, Chem. Res. Toxicol., 2008, 21, 53-69.
25. D. Basketter, C. Pease, G. Kasting, I. Kimber, S. Casati, M. Cronin, W. Diembeck, F. Gerberick, J. Hadgraft, T. Hartung, J. P. Marty, E. Nikolaidis, G. Patlewicz, D. Roberts, E. Roggen, C. Rovida and J. Van De Sandt, Skin sensitisation and epidermal disposition: The relevance of epidermal disposition for sensitisation hazard identification and risk assessment: The report and recommendations of ECVAM workshop 59a, ATLA Alternatives to Laboratory Animals, 2007, 35, 137-154.
26. M. A. Freudenberg, P. R. Esser, T. Jakob, C. Galanos and S. F. Martin, Innate and adaptive immune responses in contact dermatitis: analogy with infections, G. Ital. Dermatol. Venereol., 2009, 144, 173-185.
27. R. J. Dearman, M. Cumberbatch and I. Kimber, Cutaneous cytokine expression: Induction by chemical allergen and paracrine regulation, Journal of Toxicology - Cutaneous and Ocular Toxicology, 2003, 22, 69-86.
28. I. Kimber, M. Cumberbatch, R. J. Dearman, M. Bhushan and C. E. M. Griffiths, Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization, British Journal of Dermatology, 2000, 142, 401-412.
29. J. E. Wahlberg and A. Boman, Guinea pig maximization test, Current problems in dermatology, 1985, 14, 59-106.
30. D. A. Basketter and G. F. Gerberick, An interlaboratory evaluation of the Buehler test for the identification and classification of skin sensitizers, Contact Dermatitis, 1996, 35, 146-151.
31. P. M. McNamee, A. M. Api, D. A. Basketter, G. Frank Gerberick, D. A. Gilpin, B. M. Hall, I. Jowsey and M. K. Robinson, A review of critical factors in the conduct and interpretation of the human repeat insult patch test, Regul. Toxicol. Pharmacol., 2008, 52, 24-34.
32. D. A. Basketter, P. Evans, R. J. Fielder, G. F. Gerberick, R. J. Dearman and I. Kimber, Local lymph node assay - Validation, conduct and use in practice, Food Chem. Toxicol., 2002, 40, 593-598.
33. I. R. Jowsey, D. A. Basketter, C. Westmoreland and I. Kimber, A future approach to measuring relative skin sensitising potency: A proposal, Journal of Applied Toxicology, 2006, 26, 341-350.
34. M. Aleksic, E. Thain, D. Roger, O. Saib, M. Davies, J. Li, A. Aptula and R. Zazzeroni, Reactivity profiling: Covalent modification of single nucleophile peptides for skin sensitization risk assessment, Toxicol. Sci., 2009, 108, 401-411.
35. A. Natsch, The Nrf2-Keap1-ARE toxicity pathway as a cellular sensor for skin sensitizers-functional relevance and a hypothesis on innate reactions to skin sensitizers, Toxicol. Sci., 2010, 113, 284-292.
36. R. Emter, G. Ellis and A. Natsch, Performance of a novel keratinocytebased reporter cell line to screen skin sensitizers in vitro, Toxicol. Appl. Pharmacol., 2010, 245, 281-290.
37. E. Corsini, M. Mitjans, V. Galbiati, L. Lucchi, C. L. Galli and M. Marinovich, Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens, Toxicol. In Vitro, 2009, 23, 789-796.
38. A. Mehling, T. Eriksson, T. Eltze, S. Kolle, T. Ramirez, W. Teubner, B. Van Ravenzwaay and R. Landsiedel, Non-animal test methods for predicting skin sensitization potentials, Arch Toxicol., 2012, 86, 1273-1295.
39. OECD, The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins, Part 1: Scientific Evidence. OECD ENVIRONMENT, HEALTH AND SAFETY PUBLICATIONS, SERIES ON TESTING AND ASSESSMENT, 2012, NO. 168.
40. H. Reuter, J. Spieker, S. Gerlach, U. Engels, W. Pape, L. Kolbe, R. Schmucker, H. Wenck, W. Diembeck, K. P. Wittern, K. Reisinger and A. G. Schepky, In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells, Toxicol. In Vitro, 2011, 25, 315-323.
41. H. Sakaguchi, T. Ashikaga, N. Kosaka, S. Sono, N. Nishiyama and H. Itagaki, The in vitro skin sensitization test; human cell line activation test (h-CLAT) using THP-1 cells, Abstracts of the 44th Congress of the European Societies of Toxicology. Toxicology Letters, 2007, 172(Supp 1), S93.
42. H. Johansson, M. Lindstedt, A. S. Albrekt and C. A. Borrebaeck, A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests, BMC Genomics, 2011, 12, 399.
43. J. W. Van Der Veen, T. E. Pronk, H. Van Loveren and J. Ezendam, Applicability of a keratinocyte gene signature to predict skin sensitizing potential, Toxicol. In Vitro, 2013, 27, 314-322.
44. M. Miyazawa and A. Takashima, Development and validation of a new in vitro assay designed to measure contact allergen-triggered oxidative stress in dendritic cells, J. Dermatol. Sci., 2012, 68, 73-81.
45. K. Ouwehand, S. W. Spiekstra, J. Reinders, R. J. Scheper, T. D. De Gruijl and S. Gibbs, Comparison of a novel CXCL12/CCL5 dependent migration assay with CXCL8 secretion and CD86 expression for distinguishing sensitizers from non-sensitizers using MUTZ-3 Langerhans cells, Toxicol. In Vitro, 2010, 24, 578-585.
46. M. Vocanson, M. Cluzel-Tailhardat, G. Poyet, M. Valeyrie, C. Chavagnac, B. Levarlet, P. Courtellemont, A. Rozieres, A. Hennino and J. F. Nicolas, Depletion of human peripheral blood lymphocytes in CD25+ cells allows for the sensitive in vitro screening of contact allergens, J. Invest. Dermatol., 2008, 128, 2119-2122.
47. C. Antonopoulos, M. Cumberbatch, J. B. Mee, R. J. Dearman, X. Q. Wei, F. Y. Liew, I. Kimber and R. W. Groves, IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis, Journal of Leukocyte Biology, 2008, 83, 361-367.
48. S. F. Martin, P. R. Esser, F. C. Weber, T. Jakob, M. A. Freudenberg, M. Schmidt and M. Goebeler, Mechanisms of chemical-induced innate immunity in allergic contact dermatitis, Allergy, 2011, 66, 1152-1163.
49. P. R. Esser, U. Wolfle, C. Durr, F. D. Von Loewenich, C. M. Schempp, M. A. Freudenberg, T. Jakob and S. F. Martin, Contact Sensitizers Induce Skin Inflammation via ROS Production and Hyaluronic Acid Degradation, PLoS ONE, 2012, 7, e41340.
50. F. Gerberick, M. Aleksic, D. Basketter, S. Casati, A. T. Karlberg, P. Kern, I. Kimber, J. P. Lepoittevin, A. Natsch, J. M. Ovigne, C. Rovida, H. Sakaguchi and T. Schultz, Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64, Altern. Lab. Anim., 2008, 36, 215-242.
51. I. Chipinda, R. O. Ajibola, M. K. Morakinyo, T. B. Ruwona, R. H. Simoyi and P. D. Siegel, Rapid and simple kinetics screening assay for electrophilic dermal sensitizers using nitrobenzenethiol, Chem. Res. Toxicol., 2010, 23, 918-925.
52. G. Patlewicz, S. D. Dimitrov, L. K. Low, P. S. Kern, G. D. Dimitrova, M. I. Comber, A. O. Aptula, R. D. Phillips, J. Niemela, C. Madsen, E. B. Wedebye, D. W. Roberts, P. T. Bailey and O. G. Mekenyan, TIMESSS-a promising tool for the assessment of skin sensitization hazard. A characterization with respect to the OECD validation principles for (Q) SARs and an external evaluation for predictivity, Regul. Toxicol. Pharmacol., 2007, 48, 225-239.
53. M. D. Barratt, D. A. Basketter, M. Chamberlain, G. D. Admans and J. J. Langowski, An expert system rulebase for identifying contact allergens, Toxicology in Vitro, 1994, 8, 1053-1060.
54. Y. Dancik, M. A. Miller, J. Jaworska and G. B. Kasting, Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure, Adv. Drug Deliv. Rev., 2013, 65, 221-236.
55. M. Davies, R. U. Pendlington, L. Page, C. S. Roper, D. J. Sanders, C. Bourner, C. K. Pease and C. MacKay, Determining epidermal disposition kinetics for use in an integrated nonanimal approach to skin sensitization risk assessment, Toxicol. Sci., 2011, 119, 308-318.
56. M. A. Bergström, H. Ott, A. Carlsson, M. Neis, G. Zwadlo-Klarwasser, C. A. M. Jonsson, H. F. Merk, A. T. Karlberg and J. M. Baron, A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites, Journal of Investigative Dermatology, 2007, 127, 1145-1153.
57. S. Van Eijl, Z. Zhu, J. Cupitt, M. Gierula, C. Gotz, E. Fritsche and R. J. Edwards, Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling, PLoS ONE, 2012, 7, e41721.
58. C. Gotz, R. Pfeiffer, J. Tigges, V. Blatz, C. Jackh, E. M. Freytag, E. Fabian, R. Landsiedel, H. F. Merk, J. Krutmann, R. J. Edwards, C. Pease, C. Goebel, N. Hewitt and E. Fritsche, Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I), Exp. Dermatol., 2012, 21, 358-363.
59. C. Gotz, R. Pfeiffer, J. Tigges, K. Ruwiedel, U. Hubenthal, H. F. Merk, J. Krutmann, R. J. Edwards, J. Abel, C. Pease, C. Goebel, N. Hewitt and E. Fritsche, Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes, Exp. Dermatol., 2012, 21, 364-369.
60. E. Kiorpelidou, B. Foster, J. Farrell, M. O. Ogese, L. Faulkner, C. E. Goldring, B. K. Park and D. J. Naisbitt, IL-8 release from human neutrophils cultured with pro-haptenic chemical sensitizers, Chem. Res. Toxicol., 2012, 25, 2054-2056.
61. B. G. Modi, J. Neustadter, E. Binda and J. Lewis, R. B. Filler, S. J. Roberts, B. Y. Kwong, S. Reddy, J. D. Overton, A. Galan, R. Tigelaar, L. Cai, P. Fu, M. Shlomchik, D. H. Kaplan, A. Hayday, M. Girardi, Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma, Science, 2012, 335, 104-108.
62. A. Natsch, T. Haupt and H. Laue, Relating skin sensitizing potency to chemical reactivity: reactive Michael acceptors inhibit NF-kappaB signaling and are less sensitizing than S (N) Ar- and S (N) 2-reactive chemicals, Chem. Res. Toxicol., 2011, 24, 2018-2027.
63. C. Pickard, F. Louafi, C. McGuire, K. Lowings, P. Kumar, H. Cooper, R. J. Dearman, M. Cumberbatch, I. Kimber, E. Healy and P. S. Friedmann, The cutaneous biochemical redox barrier: a component of the innate immune defenses against sensitization by highly reactive environmental xenobiotics, J. Immunol., 2009, 183, 7576-7584.
64. K. Samuelsson, C. Simonsson, C. A. Jonsson, G. Westman, M. B. Ericson and A. T. Karlberg, Accumulation of FITC near stratum corneumvisualizing epidermal distribution of a strong sensitizer using two-photon microscopy, Contact Dermatitis, 2009, 61, 91-100.
65. D. A. Basketter and I. Kimber, Updating the skin sensitization in vitro data assessment paradigm in 2009, Journal of Applied Toxicology, 2009, 29, 545-550.
66. A. Del Bufalo, J. Bernad, C. Dardenne, D. Verda, J. R. Meunier, F. Rousset, S. Martinozzi-Teissier and B. Pipy, Contact sensitizers modulate the arachidonic acid metabolism of PMA-differentiated U-937 monocytic cells activated by LPS, Toxicol. Appl. Pharmacol., 2011, 256, 35-43.
67. C. Lass, M. Vocanson, S. Wagner, C. M. Schempp, J. F. Nicolas, I. Merfort and S. F. Martin, Anti-inflammatory and immune-regulatory mechanisms prevent contact hypersensitivity to Arnica montana L, Exp. Dermatol., 2008, 17, 849-857.
68. U. Wolfle, P. R. Esser, B. Simon-Haarhaus, S. F. Martin, J. Lademann and C. M. Schempp, UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo, Free Radic. Biol. Med., 2011, 50, 1081-1093.
69. A. Natsch, R. Emter and G. Ellis, Filling the concept with data: Integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing, Toxicol. Sci., 2009, 107, 106-121.
70. M. Miyazawa, Y. Nukada, K. Saito, H. Sakaguchi, N. Nishiyama and G. Gerberick, A novel strategy for in vitro assay platform to predict skin sensitizing potential of broad raw materials. The Toxicologist, Supplement to Toxicological Sciences, 2011, 120(Supplement 2), 548.
71. D. Kirkland, M. Aardema, L. Henderson and L. Muller, Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity, Mutat. Res., 2005, 584, 1-256.
72. C. Bauch, S. N. Kolle, T. Ramirez, T. Eltze, E. Fabian, A. Mehling, W. Teubner, B. Van Ravenzwaay and R. Landsiedel, Putting the parts together: Combining in vitro methods to test for skin sensitizing potentials, Regul. Toxicol. Pharmacol., 2012, 63, 489-504.
73. N. Ade, S. Martinozzi-Teissier, M. Pallardy and F. Rousset, Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis, Journal of Immunotoxicology, 2006, 3, 189-197.
74. H. Sakaguchi, T. Ashikaga, M. Miyazawa, Y. Yoshida, Y. Ito, K. Yoneyama, M. Hirota, H. Itagaki, H. Toyoda and H. Suzuki, Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT) II. An inter-laboratory study of the h-CLAT, Toxicology in Vitro, 2006, 20, 774-784.
75. G. F. Gerberick, J. D. Vassallo, R. E. Bailey, J. G. Chaney, S. W. Morrall and J. P. Lepoittevin, Development of a peptide reactivity assay for screening contact allergens, Toxicol. Sci., 2004, 81, 332-343.
76. A. Natsch, C. A. Ryan, L. Foertsch, R. Emter, J. Jaworska, F. Gerberick, P. Kern, A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J. Appl. Toxicol., 2013, published online, 9 April 2013, DOI:10.1002/jat.2868.
77. A. Natsch and R. Emter, Skin sensitizers induce antioxidant response element dependent genes: Application to the in vitro testing of the sensitization potential of chemicals, Toxicol. Sci., 2008, 102, 110-119.
78. J. Jaworska, A. Harol, P. S. Kern and G. F. Gerberick, Integrating nonanimal test information into an adaptive testing strategy - skin sensitization proof of concept case, ALTEX, 2011, 28, 211-225.
79. J. Jaworska, Y. Dancik, P. Kern, F. Gerberick, A. Natsch, Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice, J. Appl. Toxicol., 2013, published online, 14 May 2013, DOI: 10.1002/jat.2869.
80. C. Goebel, P. Aeby, N. Ade, N. Alepee, A. Aptula, D. Araki, E. Dufour, N. Gilmour, J. Hibatallah, D. Keller, P. Kern, A. Kirst, M. Marrec-Fairley, G. Maxwell, J. Rowland, B. Safford, F. Schellauf, A. Schepky, C. Seaman, T. Teichert, N. Tessier, S. Teissier, H. U. Weltzien, P. Winkler and J. Scheel, Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation, Regul. Toxicol. Pharmacol., 2012, 63, 40-52.
81. D. W. Roberts and A. Natsch, High throughput kinetic profiling approach for covalent binding to peptides: Application to skin sensitization potency of michael acceptor electrophiles, Chem. Res. Toxicol., 2009, 22, 592-603.
82. A. Natsch, H. Gfeller, F. Kuhn, T. Granier and D. W. Roberts, Chemical Basis for the Extreme Skin Sensitization Potency of (E)-4-(Ethoxymethylene) - 2-phenyloxazol-5 (4H)-one, Chem. Res. Toxicol., 2010, 23, 1913-1920.
83. A. Natsch, H. Gfeller, T. Haupt and G. Brunner, Chemical reactivity and skin sensitization potential for benzaldehydes: can schiff base formation explain everything?, Chem. Res. Toxicol., 2012, 25, 2203-2215.